Skip to main content
Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
7.84
+0.04 (0.51%)
Dec 20, 2024, 4:00 PM EST - Market closed

Cogent Biosciences Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
164
Market Cap
866.02M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 20207.87M-14.63M-65.02%
Dec 31, 201922.50M14.14M169.13%
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AMN Healthcare Services 3.07B
Aveanna Healthcare Holdings 1.98B
Phibro Animal Health 1.05B
Paragon 28 245.00M
Prothena Corporation 133.35M
Immatics 128.82M
AbCellera Biologics 32.96M
uniQure 28.59M
Revenue Rankings

COGT News

More News